Institute of Endocrinology, Narodni 8, 11694 Prague, Czech Republic.
Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Technicka 6, 16628 Prague, Czech Republic.
Int J Mol Sci. 2021 Jan 5;22(1):466. doi: 10.3390/ijms22010466.
Androgens represent the main hormones responsible for maintaining hormonal balance and function in the prostate and testis. As they are involved in prostate and testicular carcinogenesis, more detailed information of their active concentration at the site of action is required. Since the introduction of the term intracrinology as the local formation of active steroid hormones from inactive precursors of the adrenal gland, mainly dehydroepiandrosterone (DHEA) and DHEA-S, it is evident that blood circulating levels of sex steroid hormones need not reflect their actual concentrations in the tissue. Here, we review and critically evaluate available methods for the analysis of human intraprostatic and intratesticular steroid concentrations. Since analytical approaches have much in common in both tissues, we discuss them together. Preanalytical steps, including various techniques for separation of the analytes, are compared, followed by the end-point measurement. Advantages and disadvantages of chromatography-mass spectrometry (LC-MS, GC-MS), immunoanalytical methods (IA), and hybrid (LC-IA) are discussed. Finally, the clinical information value of the determined steroid hormones is evaluated concerning differentiating between patients with cancer or benign hyperplasia and between patients with different degrees of infertility. Adrenal-derived 11-oxygenated androgens are mentioned as perspective prognostic markers for these purposes.
雄激素是维持前列腺和睾丸激素平衡和功能的主要激素。由于它们参与了前列腺和睾丸癌的发生,因此需要更详细的信息了解它们在作用部位的活性浓度。自从引入“胞内甾体学”这一术语以来,即肾上腺的非活性前体(主要是脱氢表雄酮 (DHEA) 和 DHEA-S)可在局部形成有活性的甾体激素,很明显,循环血液中的性激素水平不一定反映其在组织中的实际浓度。在这里,我们回顾和批判性地评估了用于分析人类前列腺内和睾丸内甾体浓度的现有方法。由于这两种组织中的分析方法有很多共同之处,因此我们一起进行讨论。比较了包括分析物分离的各种技术的分析前步骤,然后是终点测量。讨论了色谱-质谱联用 (LC-MS、GC-MS)、免疫分析方法 (IA) 和混合 (LC-IA) 的优缺点。最后,根据确定的甾体激素在区分癌症或良性增生患者以及不同程度不育患者方面的临床信息价值进行了评估。对于这些目的,提到了源自肾上腺的 11-氧化雄激素作为有前途的预后标志物。